HomeNewsTrendsSportsCommercial break: The 'pause' on IPL is good for big game ad campaigns
Trending Topics

Commercial break: The 'pause' on IPL is good for big game ad campaigns

Many campaigns lose momentum by week three. The break could provide marketers with an opportunity to create a second burst when play resumes. But there’s a big IF.

May 07, 2021 / 16:28 IST
Story continues below Advertisement
The Indian Premier League trophy (Image courtesy: Twitter/@IPL, BCCI)
The Indian Premier League trophy (Image courtesy: Twitter/@IPL, BCCI)

The Indian Premier League - the distraction from the distressing reality of life, came to a screeching halt after the Covid-19 virus infiltrated the bio-bubble designed to keep players and staff safe.

So what happens now? Players go home. Via Maldives. Advertisers are probably feeling the same degree of rage as Indiranagar ka gunda. Use words, not bats. Star Sports, the broadcaster, is in a jam. Losses for the world’s richest cricket board, BCCI, could be way north of Rs 2000 crore, according to reports.

Story continues below Advertisement

Over 18 sponsors and over 100 advertisers threw open their purses in the middle of a pandemic to get their brand on every piece of IPL real estate. Nothing was spared. The result: A traffic jam of ads and logos on players, on the pitch, and on our screens. Commercial breaks were packed with dancing celebrities and cricketers with anger-management issues. And MS Dhoni. Star Sports had increased the rate of ad slots this year from Rs 12 lakh for ten seconds to Rs13 lakh.

Where do the big advertisers go? Nowhere, for now. They wait for the ‘pause’ to end and play again. Besides, there’s no match for the IPL in terms of scale and attraction for advertisers. Even in a bad year. Television viewership of IPL 2021 was down almost 10% from last year, which prompted many advertisers to rework ad deals.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show